Abstract EP112 Table 1

Patient demographics and baseline data

Control (n=44)Intervention (n=44)Pvalue
Male sex, n (%) 31 (70.5) 25 (56.8) 0.268
Age, yr 51.5 (41.0-59.5) 53.5 (46.0-62.0) 0.416
Height, cm 166.2 ± 7.6 164.3 ± 7.5 0.243
Weight, kg 64.5 [57.0-71.0] 62.5 [55.0-74.0] 0.605
BMl,kgm-2 22.4 [21.3-26.4] 24.1 [21.1-26.1] 0.997
ASA class, n (%) 0.084
II 8 (18.2) 3 (6.8)
TTT 35 (79.5) 36 (81.8)
IV 1 (2.3) 5 (11.4)
Comorbidities, n (%)
Hypertension 28 (63.6) 26(59.1) 0.827
Diabetes mellitus 9 (20.5) 12 (27.3) 0.617
Chronic liver disease 1 (2.3) 2 (4.5) 1.000
Pulmonary disease 2 (4.5) 1 (2.3) 1.000
Others 11 (25.0) 12 (27.3) 1.000
Operation time (min) 222.9 ± 47.7 217.6 ± 40.8 0.582
Aneslhesia Lime (min) 277.4 ± 44.9 279.0 ± 46.8 0.874
lntraoperative remifentanil consumption (µg) 961.5 [654-1450] 800 [704-1030.5] 0.367
  • Values are mean ± SD or median [IQR] or number (percentage).

  • Abbrevialions: BMI, body mass index (calculaled as weight in kilograms divided by heighl in melres squared); ASA, American Society of Anesthesiologists; SD, standard deviation; 1.QR, interquartile range.